JP2000506895A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506895A5
JP2000506895A5 JP1997533600A JP53360097A JP2000506895A5 JP 2000506895 A5 JP2000506895 A5 JP 2000506895A5 JP 1997533600 A JP1997533600 A JP 1997533600A JP 53360097 A JP53360097 A JP 53360097A JP 2000506895 A5 JP2000506895 A5 JP 2000506895A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997533600A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506895A (ja
Filing date
Publication date
Priority claimed from US08/621,169 external-priority patent/US5889038A/en
Application filed filed Critical
Publication of JP2000506895A publication Critical patent/JP2000506895A/ja
Publication of JP2000506895A5 publication Critical patent/JP2000506895A5/ja
Pending legal-status Critical Current

Links

JP9533600A 1996-03-20 1997-03-20 下痢治療におけるクロトリマゾールおよび関連化合物の使用 Pending JP2000506895A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/621,169 1996-03-20
US08/621,169 US5889038A (en) 1996-03-20 1996-03-20 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
PCT/US1997/004244 WO1997034599A2 (en) 1996-03-20 1997-03-20 Use of clotrimazole and related compounds in the treatment of diarrhea

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008184496A Division JP2009007368A (ja) 1996-03-20 2008-07-16 下痢治療におけるクロトリマゾールおよび関連化合物の使用

Publications (2)

Publication Number Publication Date
JP2000506895A JP2000506895A (ja) 2000-06-06
JP2000506895A5 true JP2000506895A5 (enExample) 2004-12-02

Family

ID=24489031

Family Applications (2)

Application Number Title Priority Date Filing Date
JP9533600A Pending JP2000506895A (ja) 1996-03-20 1997-03-20 下痢治療におけるクロトリマゾールおよび関連化合物の使用
JP2008184496A Pending JP2009007368A (ja) 1996-03-20 2008-07-16 下痢治療におけるクロトリマゾールおよび関連化合物の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008184496A Pending JP2009007368A (ja) 1996-03-20 2008-07-16 下痢治療におけるクロトリマゾールおよび関連化合物の使用

Country Status (9)

Country Link
US (3) US5889038A (enExample)
EP (1) EP0910376B1 (enExample)
JP (2) JP2000506895A (enExample)
AT (1) ATE245981T1 (enExample)
DE (1) DE69723843T2 (enExample)
DK (1) DK0910376T3 (enExample)
ES (1) ES2199358T3 (enExample)
PT (1) PT910376E (enExample)
WO (1) WO1997034599A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
BR9708230A (pt) 1996-03-20 2000-01-04 Harvard College Compostos de triaril metano, composição farmacêutica, e métodos de inibição do transporte de potássio ativado por cálcio de uma célula, para reduzir a desidrataçào de eritrócito falciforme e/ou retaradar a ocorrência de afoiçamento ou deformação de eritrócitos, e tratamento ou prevenção de doença, de inibição da proliferação celular em mamìferos, e de tratamento ou prevenção de uma desordem.
US5889038A (en) * 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
US6667063B2 (en) * 1998-06-10 2003-12-23 Albert Crum Nutritional or therapeutic supplement and method
ATE400551T1 (de) 2002-01-04 2008-07-15 Neurosearch As Kaliumkanal-modulatoren
WO2003080082A1 (en) * 2002-03-21 2003-10-02 Anadis Ltd Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
US10066254B2 (en) * 2002-05-20 2018-09-04 Cedars-Sinai Medical Center Diagnosis of constipation by analysis of methane concentration
EP1505989B1 (en) 2002-05-20 2011-02-23 Cedars-Sinai Medical Center Manipulation of the rate of gastrointestinal transit by modulating intestinal methane concentration
US9072728B2 (en) * 2003-09-18 2015-07-07 Children's Medical Center Corporation Treatment of severe distal colitis
US20060013890A1 (en) * 2004-06-24 2006-01-19 Green Shawn J Dairy-derived anticholesterol immunoglobulin to lower dietary cholesterol in humans
US20070087002A1 (en) * 2005-10-14 2007-04-19 Green Shawn J Anticholesterol immunoglobulin to treat lipid raft diseases
AU2008259342B2 (en) * 2007-06-04 2014-07-10 Ben-Gurion University Of The Negev Research And Development Authority Tri-aryl compounds and compositions comprising the same
ATE494891T1 (de) 2007-08-24 2011-01-15 Neurosearch As Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung
KR101345860B1 (ko) 2011-10-25 2013-12-30 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 치료용 조성물
WO2014152754A2 (en) 2013-03-15 2014-09-25 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
CN103266281B (zh) * 2013-05-24 2015-02-04 无锡鑫常钢管有限责任公司 一种超级双相不锈钢管及其生产工艺
EA201690938A1 (ru) 2013-11-05 2016-11-30 Бен-Гурион Юниверсити Оф Дзе Негев Рисерч Энд Дивелопмент Оторити Соединения для лечения диабета и осложнений, возникающих из-за этого заболевания
AU2015301596B2 (en) 2014-08-13 2020-04-16 Cedars-Sinai Medical Center Anti-methanogenic compositions and uses thereof
WO2016161085A1 (en) 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
MX2021008560A (es) * 2019-01-16 2021-09-21 Univ California Métodos de tratamiento de la diarrea inducida por inhibidor de tirosina cinasa.
JP6664637B1 (ja) * 2019-08-08 2020-03-13 株式会社 レオロジー機能食品研究所 ストレス低下用及び/又は体重回復用経口組成物、並びにプラズマローゲン含有組成物の製造方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US307874A (en) * 1884-11-11 Bessemer converter
US3655882A (en) * 1968-08-26 1972-04-11 Staley Mfg Co A E Stable dietary supplement for new born pigs
US3965112A (en) * 1971-01-11 1976-06-22 John Wyeth & Brother Limited Imidazoline derivatives
CA1007568A (en) * 1973-12-13 1977-03-29 Michael C. Attwell Bovine immunoglobulin isolation process
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines
US3998832A (en) * 1975-04-16 1976-12-21 G. D. Searle & Co. Anti-diarrheal compounds
US4284829A (en) * 1977-09-13 1981-08-18 Pfizer Inc. Hydroxyalkyl and oxoalkyl substituted phenols as analgesics and sedatives
US4806685A (en) 1985-08-05 1989-02-21 Gyogyszerkutato Inteezet/Pharmaceutical Research Institute 1,1,2-triphenylpropane and -propene derivatives
JPS62163662A (ja) * 1986-01-11 1987-07-20 Nippon Nousan Kogyo Kk 犬猫用ペツトフ−ド
KR970009887B1 (ko) 1987-12-24 1997-06-19 존 에이취. 뉴만 심방의 나트륨이뇨성 펩티드의 선형유사체
AU629559B2 (en) * 1988-08-04 1992-10-08 Thomas Julius Borody Oral antibody therapy for patients with lowered immune response and composition therefor
AU5254790A (en) * 1989-04-06 1990-10-11 Chugai Seiyaku Kabushiki Kaisha Process for preparing a therapeutic agent for rotavirus infection
CA2081388A1 (en) * 1990-04-09 1991-10-10 Jonah Shacknai Antidiarrheal composition and method
DE4130689A1 (de) * 1991-09-14 1993-03-18 Biotest Pharma Gmbh Verfahren zur herstellung eines leicht loeslichen getrockneten immunglobulin-praeparats aus kolostralmilch
US5430062A (en) 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5387600A (en) 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
US5512591A (en) 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
US5439086A (en) * 1993-12-10 1995-08-08 Oceaneering International, Inc. Mechanical clutch
FR2715068B1 (fr) * 1994-01-17 1996-04-19 Paul Vidal Procédé permettant de recueillir des doses de sérocolostrum bovin destinées à être administrées par voie orale à des veaux nouveau-nés ainsi que dispositif permettant la mise en Óoeuvre de ce procédé.
US5650425A (en) 1994-04-04 1997-07-22 Pharmos Corporation Permanently ionic derivatives of steroid hormones and their antagonists
WO1996001107A1 (en) 1994-07-06 1996-01-18 Bo Arne Hofmann Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DE69534632T2 (de) * 1994-09-16 2006-06-14 Childrens Medical Center Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit
BR9708230A (pt) 1996-03-20 2000-01-04 Harvard College Compostos de triaril metano, composição farmacêutica, e métodos de inibição do transporte de potássio ativado por cálcio de uma célula, para reduzir a desidrataçào de eritrócito falciforme e/ou retaradar a ocorrência de afoiçamento ou deformação de eritrócitos, e tratamento ou prevenção de doença, de inibição da proliferação celular em mamìferos, e de tratamento ou prevenção de uma desordem.
US5889038A (en) 1996-03-20 1999-03-30 Children's Hospital Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
EP1052990A2 (en) 1997-11-14 2000-11-22 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction

Similar Documents

Publication Publication Date Title
JP2000511787A5 (enExample)
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2001504093A5 (enExample)
JP2000504884A5 (enExample)
JP2000501599A5 (enExample)
JP2001514785A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000502485A5 (enExample)
JP2001511768A5 (enExample)
JP2000504828A5 (enExample)
JP2000502568A5 (enExample)
JP2002508086A5 (enExample)
JP2000501774A5 (enExample)
JP2001500658A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000515323A5 (enExample)
JP2000501744A5 (enExample)
JP2001502411A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2001506797A5 (enExample)
JP2000501569A5 (enExample)